( NASDAQ-NMS:RGLS )

News from Regulus Therapeutics Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Feb 16, 2017, 08:30 ET Regulus Announces Publication in Nature Communications Identifying miR-17 as a Promising Drug Target for ADPKD

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Feb 08, 2017, 16:10 ET Regulus to Present at Upcoming Healthcare Conferences

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Jan 27, 2017, 16:10 ET Regulus Announces Continuation of RG-101 Clinical Hold

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Dec 06, 2016, 16:10 ET Regulus Announces New Drug Development Candidates

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Nov 22, 2016, 08:00 ET Regulus to Announce New Drug Development Candidates at R&D Day on December 6, 2016

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Nov 01, 2016, 16:10 ET Regulus Reports Third Quarter 2016 Financial Results

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Oct 25, 2016, 16:15 ET Regulus to Release Third Quarter Financial Results on November 1, 2016

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Oct 06, 2016, 16:15 ET Regulus Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Oct 05, 2016, 08:00 ET Regulus Appoints Timothy M. Wright, M.D. as Chief Research and Development Officer

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Aug 31, 2016, 08:00 ET Regulus to Present at the 2016 Wells Fargo Healthcare Conference

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Aug 09, 2016, 16:10 ET Regulus to Present at the 2016 Wedbush PacGrow Healthcare Conference

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Aug 02, 2016, 16:10 ET Regulus Reports Second Quarter 2016 Financial Results

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Jul 27, 2016, 16:10 ET Regulus Provides Update on Clinical Hold of RG-101

 Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines...


Jul 26, 2016, 16:15 ET Regulus to Release Second Quarter Financial Results on August 2, 2016

 Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Jul 05, 2016, 08:00 ET Regulus to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Jun 27, 2016, 16:10 ET Regulus Reports Clinical Hold of RG-101

 Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative...


Jun 20, 2016, 07:00 ET Regulus Secures $30 Million Growth Capital Credit Facility

 Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Jun 07, 2016, 07:00 ET Regulus Reports Positive Top-line Data

Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Jun 03, 2016, 08:00 ET Regulus to Present at the Jefferies 2016 Healthcare Conference

Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Jun 02, 2016, 16:15 ET Dr. Hugh Rosen Joins Regulus Board of Directors

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Jun 01, 2016, 08:00 ET Regulus Expands Clinical Trial Collaboration with GSK

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


May 23, 2016, 08:00 ET Regulus Appoints Allison Wey as Vice President, Investor Relations & Corporate Communications

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


May 20, 2016, 08:00 ET Regulus to Present New RG-012 Data at The 53rd European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Congress

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


May 18, 2016, 16:05 ET Regulus to Present at the 2016 UBS Global Healthcare Conference

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


May 04, 2016, 16:05 ET Regulus to Present at the Bank of America Merrill Lynch 2016 Healthcare Conference

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...